distribution agreement for middle east

INJEX Pharma signs an exclusive distribution agreement with Al-Shamali Group for the needle-free syringe INJEX30 for the Middle East.

INJEX Pharma GmbH has expanded recently its signed contract with Al-Shamali GROUP Co. (BOUBYAN MEDICAL) for the needle-free syringe INJEX30 for the entire Middle East.

Centralized marketing, led by a strong partner in the Middle East region, will ensure a stable and continuous pricing policy, as well as a uniform marketing appearance.  Partners in these countries will rely on the centrally created promotional material, such as brochures and TV spots, and thus aims to enhance synergies.

A central warehouse will be set up in Dubai enabling the partners to place orders with relative ease. INJEX Pharma can supply its customers at short notice with the added advantage of low cost transport by ship. The general manager, Dr. Wael Elghamri of Boubyan Medical (The pharmaceutical division of Al-Shamali Group) has initiated various registrations processes with the national Ministry of Health (MOH) Among these countries are: Kuwait, UAE, Qatar, Jordan, Lebanon, Oman, Bahrain, Egypt and the Kingdom of Saudi Arabia. An initial order has been confirmed and is on its way to distributors. The order will reach them before the ARAB HEALTH Fair in Dubai begins.
 
'We are very pleased that the Middle East is now guided by the successful and centrally managed marketing of INJEX30.  For all participants, this advantage of local collaboration will improve and generate greater value added within this area “said Andy Rösch, CEO of Paketeria AG / INJEX Pharma AG.”

The rate of diabetes in the Middle East is one of the highest in the world. Ten million people have diabetes and 1.5 million of these patients need an insulin injection daily.  The Al-Shamali Group’s objective is to operate in this region and to achieve approximately 25% of the market share in the next three years
 
The INJEX Pharma GmbH was merged into Paketeria AG to 100% at the shareholders annual meeting on the 16th of December.  The official statement of the change of name is expected shortly from the district court from Berlin.